00882 TIANJIN DEV
- 1.960
- 0.0000.00%
TIANJIN DEV News
TIANJIN DEV (00882.HK): Xia Binhui has been appointed as Executive Director and Deputy General Manager.
Gelonghui reported on December 30 that TIANJIN DEV (00882.HK) announced that the Board of Directors has appointed Xia Binhui as the company's executive director and deputy general manager, effective from December 30, 2024.
TIANJIN DEV (00882): Xia Binhui has been appointed as Executive Director.
TIANJIN DEV (00882) announced that Xia Binhui has been appointed as the company's executive Director and vice general manager, starting from 2024...
Express News | Tianjin Development Holdings Ltd - Xia Binhui Appointed as Executive Director
Tianjin Development Subsidiary to Repurchase Shares, Grant Shares Under Share Award Scheme
Tianjin DEV (00882.HK) subsidiary Tianjin Lisheng Pharmaceutical plans to repurchase shares and adopt a stock incentive plan.
On December 20, Grizzly Holdings announced that TIANJIN DEV (00882.HK) has approved a share buyback plan at the Board of Directors of Tianjin Lisheng Pharmaceutical (a non-wholly-owned subsidiary indirectly listed on the Shenzhen Stock Exchange) on December 20, 2024. Accordingly, starting from December 21, 2024, within a period of twelve months, Tianjin Lisheng Pharmaceutical is allowed to repurchase its ordinary shares through centralized bidding on the Shenzhen Stock Exchange at the current market price, with a total amount not less than 76.5 million yuan and not exceeding 0.153 billion yuan. The Board of Directors of Tianjin Lisheng Pharmaceutical recommends that this be approved by its Shareholders at the Shareholders' meeting.
Express News | Tianjin Development - Unit to Conduct Repurchase of Ordinary Shares for Not Less Than RMB76.5 Mln and up to RMB153 Mln
Express News | Tianjin Development -Co to Borrow From Revolving Loan Facility of HK$100 Mln
Tianjin Development Renews Service Contracts With Associate
tianjin dev (00882): tianjin lisheng pharmaceutical's net income attributable to parent company for the first three quarters was 0.169 billion yuan
Tianjin dev (00882) announced that its indirectly non-wholly-owned subsidiary tianjin lisheng pharmaceutical has until September 3, 2024...
Express News | Tianjin Development - 9-Mth Net Profit Attributable RMB169.3 Mln for Tianjin Lisheng Pharmaceutical
TIANJIN DEV: Unaudited Financial Results for the nine months ended 30 September 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Tianjin Lisheng Invests 210 Million Yuan in China Bohai Bank's Structured Deposit
tianjin dev (00882.HK) subsidiary subscribed 0.21 billion yuan to another structured deposit.
Gelonghui September 26th, Tianjin Development (00882.HK) announced that due to the expiration of the previous structured deposits, on September 26, 2024, the company's indirectly non-wholly-owned subsidiary Tianjin Lisheng Pharmaceutical and CBHB signed a third CBHB wealth management agreement, subscribing to another structured deposit with a principal amount of 0.21 billion yuan.
Express News | Tianjin Development - Subscription of Wealth Management Product
Tianjin Development Holdings (HKG:882) Strong Profits May Be Masking Some Underlying Issues
TIANJIN DEV: 2024 Interim Report
Tianjin Development Holdings Books Lower Profit, Revenue in H1
tianjin dev (00882.HK) has a net profit of approximately 0.288 billion Hong Kong dollars for the interim period, with an interim dividend of 5.18 Hong Kong cents.
Great Connection August 29th, Tianjin Dev (00882.HK) announced that for the six months ended June 30, 2024, the company's income was approximately HK$1,820,260,000 (same period last year: HK$1,830,477,000). The attributable profit to owners of the company was approximately HK$288,077,000 (same period last year: HK$371,509,000). Basic earnings per share were 26.85 HK cents, with an interim dividend of 5.18 HK cents per share (same period last year: 3.45 HK cents per share).
Express News | Tianjin Development Holdings Ltd - Hy Revenue HK$1.82 Bln
Express News | Tianjin Development - Interim Dividend of HK5.18 Cents per Share
No Data
